None listed
Conditions
Brief summary
Patellofemoral pain syndrome (PFPS) is a common musculoskeletal problem more known as "knee pain", characterized by pain in the anterior aspect of the knee that tends to become chronic. Non-operative treatments are frequent, and physiotherapy is a commonly used intervention. Therefore, we will use an electrotherapy procedure consisting of the application of monopolar dielectric diathermy by radiofrequency. This type of therapy is well known in the field of physiotherapy; although, there are hardly any relevant studies as far as their application is concerned with the PFPS. The aim of this study is to analyze the effectiveness of monopolar dielectric diathermy by radiofrequency in the reduction of knee pain, functional disability and degree of psychological apprehension of patients with the syndrome of patellofemoral pain. Participants will receive either 10 sessions of 12 minutes of monopolar dielectric diathermy or 10 sessions of 12 minutes of non-emission treatment. Several outcomes will be assessed: pain, knee function, range of motion and temperature.
Interventions
Intervention group will receive 10 sessions of 12 minutes of radiofrequency along three weeks: first week from Monday to Friday, second week on Monday, Wednesday and Friday, third week on Tuesday and Thursday.
The treatment will be applied by a Physiotherapist with over 10 years of experience with a 600-800kHz pulsed emission radio frequency device. A dose of 30 volts will be used applied on a 100cm2 at the participant knee.
Treatment will be delivered in a ambulatory facility under health an
Intervention group will receive 10 sessions of 12 minutes of radiofrequency along three weeks: first week from Monday to Friday, second week on Monday, Wednesday and Friday, third week on Tuesday and Thursday. The treatment will be applied by a Physiotherapist with over 10 years of experience with a 600-800kHz pulsed emission radio frequency device. A dose of 30 volts will be used applied on a 100cm2 at the participant knee. Treatment will be delivered in a ambulatory facility under health and clinic conditions required by current legislation
Sponsors
Biotronic Advance Develops
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
Participants between 18 and 60 years old and diagnosed of patelofemoral syndrome with over 6 months of evolution
Exclusion criteria
-Under antitumoral treatment -People with pacemaker -Undergone knee surgery in last six months
Outcome results
None listed